Filing Details

Accession Number:
0001209191-14-023462
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-27 16:24:23
Reporting Period:
2014-03-26
Filing Date:
2014-03-27
Accepted Time:
2014-03-27 16:24:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532233 Brian Bernick 6800 Broken Sound Parkway Nw
Third Floor
Boca Raton FL 33487
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-26 421,268 $6.70 6,735,999 No 4 S Indirect By BF Investment Enterprises, Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By BF Investment Enterprises, Ltd.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 297,000 Direct
Common Stock 3,000 Indirect By BF Management, LLC
Footnotes
  1. The reported securities are owned by BF Investment Enterprises, Ltd. ("BF Investment"). The reporting person (i) holds, together with his spouse as tenants by the entirety, 70.6% membership interest in BF Management, LLC (the "GP"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The reporting person disclaims beneficial ownership of TherapeuticsMD, Inc. (the "Company") common stock except to the extent of his pecuniary interest therein.
  2. The reported securities are held by the GP. As disclosed in footnote 1 above, the reporting person, together with his spouse as tenants by the entirety, hold 70.6% membership interest in the GP. The reporting person disclaims beneficial ownership of the Company common stock except to the extent of his pecuniary interest therein.